| Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial 1995 · Rifaximin group · Outpatients with symptomatic uncomplicated diverticular disease of the colon | 2 g | 1 year | 84 |
| Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial 1995 · Placebo group · Outpatients with symptomatic uncomplicated diverticular disease of the colon | 2 g | 1 year | 84 |
| [Use of glucomannan dietary fiber in changes in intestinal habit] 1995 · Glucomannan 3 gr/day · Patients; age and sex not reported; condition not specified | 3 g | 5 weeks | — |
| Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon 2003 · Fiber supplementation with glucomannan plus rifaximin · Outpatients with uncomplicated symptomatic diverticular disease | 4 g | 1 year | 558 |
| Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon 2003 · Glucomannan alone · Outpatients with uncomplicated symptomatic diverticular disease | 4 g | 1 year | 346 |
| Fiber (glucomannan) is beneficial in the treatment of childhood constipation 2004 · fiber (glucomannan) · Children aged 4.5–11.7 years with functional constipation, with or without encopresis | 100 mg/kg | 4 weeks | 31 |
| [Chronic use of glucomannan in the dietary treatment of severe obesity] 1992 · diet + glucomannan group · Severely obese patients; age and sex not stated | 4 g | 90 days | 25 |
| Konjac acts as a natural laxative by increasing stool bulk and improving colonic ecology in healthy adults 2006 · KGM-supplemented period · Healthy adults; age and sex not specified | 4.5 g | 3 weeks | 8 |
| Supplementation of konjac glucomannan into a low-fiber Chinese diet promoted bowel movement and improved colonic ecology in constipated adults: a placebo-controlled, diet-controlled trial 2008 · KGM-supplemented period · Constipated adults who passed a bowel movement less than once a day; age range and sex not specified | 4.5 g | 3 weeks | 7 |
| Gummies candy enriched with Konjac glucomannan reduces hunger intensity and waist circumference of overweight individuals 2023 · KGM-enriched gummy candy · Overweight adults aged 18–45 years; sex not specified | 250 mg | 2 weeks | — |
| [Use of glucomannan dietary fiber in changes in intestinal habit] 1995 · Glucomannan 4 gr/day · Patients; age and sex not reported; condition not specified | 4 g | 5 weeks | — |
| Effects of a carbohydrate-restricted diet with and without supplemental soluble fiber on plasma low-density lipoprotein cholesterol and other clinical markers of cardiovascular risk 2007 · soluble fiber group · overweight and obese men with BMI 25–35 kg/m² | 3 g | 12 weeks | 15 |
| The Impact of Glucomannan, Inulin, and Psyllium Supplementation (Soloways(TM)) on Weight Loss in Adults with FTO, LEP, LEPR, and MC4R Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial 2024 · glucomannan, inulin, and psyllium · Adults aged 40–60 with BMI of at least 25 and at least one minor allele in a specified FTO, LEP, LEPR, or MC4R polymorphism | 3 g | 180 days | 75 |
| Evaluation of the pharmacotherapeutic efficacy of Garcinia cambogia plus Amorphophallus konjac for the treatment of obesity 2008 · treatment group · Adults with obesity, BMI 30.0–39.9 kg/m²; sex and age range not reported | 1.5 g | 12 weeks | 32 |
| Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial 2008 · b.i.d. group · Overweight or obese patients; age and sex not specified | 2 g | 16 weeks | — |
| Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial 2008 · t.i.d. group · Overweight or obese patients; age and sex not specified | 3 g | 16 weeks | — |
| Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes 2006 · glucomannan · Adults aged 38–74 years, mildly hypercholesterolemic, with or without type II diabetes | 10 g | 3 weeks | 34 |
| Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Cinnamomum zeylanicum Blume and Inulin in Patients with Metabolic Syndrome 2024 · oral supplement group · Adults over 18 with overweight and metabolic syndrome, including people with type 2 diabetes or impaired glucose tolerance; men and women | 1 g | 16 weeks | 29 |
| Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men 1995 · konjac glucomannan (GM) · healthy men | 3.9 g | 4 weeks | 63 |
| Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects--a randomized double-blind trial 2003 · konjac glucomannan (KGM) supplement · Adults with hyperlipidemic type 2 diabetes; mean age 64.2 years, mean BMI 25.5 kg/m² | 3.6 g | 4 weeks | 22 |
| Glycemic and lipid responses to glucomannan in Thais with type 2 diabetes mellitus 2007 · glucomannan intervention · Adults with type 2 diabetes mellitus; 10 men and 10 women | 3 g | 4 weeks | 20 |
| Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults 2017 · 98 g HFF + 2 g KM · Apparently healthy adults; mean age 37 ± 9 years; 3 men and 35 women among completers | 2 g | 1 day | 13 |
| The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism 2007 · Group I · Newly diagnosed adults with hyperthyroidism, including patients with Graves' disease or multinodular goitre; age and sex not reported | 2.6 g | 60 days | — |
| Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults 2017 · 96 g HFF + 4 g KM · Apparently healthy adults; mean age 37 ± 9 years; 3 men and 35 women among completers | 4 g | 1 day | 13 |
| Ameliorative effects of konjac glucomannan on human faecal β-glucuronidase activity, secondary bile acid levels and faecal water toxicity towards Caco-2 cells 2011 · konjac glucomannan · Adult volunteers consuming a low-fibre diet; no condition stated | 4.5 g | 4 weeks | — |
| Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes 2006 · combination of glucomannan and plant sterols · Adults aged 38–74 years, mildly hypercholesterolemic, with or without type II diabetes | 10 g | 3 weeks | 34 |
| Relationship between the Peroxidation of Leukocytes Index Ratio and the Improvement of Postprandial Metabolic Stress by a Functional Food 2016 · HFHCM + Snello cookie (HFHCM-S) · Healthy men and women aged 25–50 years | 2.4 g | 1 day | 10 |